Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (600671) — Financial Flexibility Index
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (600671) has a Financial Flexibility Index of -0.04x as of September 2025. Free cash flow of CN¥-12.90 Million (operating CF CN¥-19.96 Million minus capex CN¥7.06 Million) represents 0% of total liabilities (CN¥335.43 Million). Check Hangzhou TianMuShan Pharmaceutical Enter (600671) strategic investment index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd across 28 annual periods. See 600671 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd (1998–2025)
Year-by-year free cash flow to debt coverage for Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd. For the full company profile including market capitalisation, see market value of Hangzhou TianMuShan Pharmaceutical Enter.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.12x | CN¥42.97 Million | CN¥11.79 Million | CN¥348.04 Million | ▲ +373.0% |
| 2024 | -0.05x | CN¥-16.12 Million | CN¥-36.67 Million | CN¥356.44 Million | ▼ -14.5% |
| 2023 | -0.04x | CN¥-11.47 Million | CN¥-20.43 Million | CN¥290.34 Million | ▲ +26.4% |
| 2022 | -0.05x | CN¥-15.85 Million | CN¥-19.37 Million | CN¥295.36 Million | ▲ +16.4% |
| 2021 | -0.06x | CN¥-21.71 Million | CN¥-26.42 Million | CN¥338.09 Million | ▼ -751.8% |
| 2020 | 0.01x | CN¥3.44 Million | CN¥-8.40 Million | CN¥349.18 Million | ▼ -98.5% |
| 2019 | 0.65x | CN¥255.78 Million | CN¥161.13 Million | CN¥393.60 Million | ▲ +139.7% |
| 2018 | 0.27x | CN¥108.17 Million | CN¥70.71 Million | CN¥398.99 Million | ▲ +10.7% |
| 2017 | 0.24x | CN¥86.77 Million | CN¥24.52 Million | CN¥354.18 Million | ▲ +119.2% |
| 2016 | 0.11x | CN¥26.82 Million | CN¥1.61 Million | CN¥240.01 Million | ▲ +113.0% |
| 2015 | 0.05x | CN¥11.42 Million | CN¥-1.47 Million | CN¥217.63 Million | ▼ -66.2% |
| 2014 | 0.16x | CN¥31.11 Million | CN¥653.79K | CN¥200.40 Million | ▲ +48.9% |
| 2013 | 0.10x | CN¥23.98 Million | CN¥12.37 Million | CN¥230.01 Million | ▲ +210.1% |
| 2012 | -0.09x | CN¥-19.24 Million | CN¥-19.82 Million | CN¥203.17 Million | ▼ -6231.4% |
| 2011 | 0.00x | CN¥-261.74K | CN¥-6.49 Million | CN¥175.00 Million | ▼ -126.7% |
| 2010 | 0.01x | CN¥928.13K | CN¥-12.60 Million | CN¥165.66 Million | ▼ -97.8% |
| 2009 | 0.26x | CN¥36.33 Million | CN¥7.58 Million | CN¥140.53 Million | ▼ -12.1% |
| 2008 | 0.29x | CN¥37.88 Million | CN¥21.19 Million | CN¥128.78 Million | ▼ -70.6% |
| 2007 | 1.00x | CN¥131.36 Million | CN¥47.53 Million | CN¥131.16 Million | ▲ +67.7% |
| 2006 | 0.60x | CN¥69.29 Million | CN¥55.39 Million | CN¥116.04 Million | ▲ +297.6% |
| 2005 | 0.15x | CN¥20.02 Million | CN¥8.48 Million | CN¥133.32 Million | ▲ +62.0% |
| 2004 | 0.09x | CN¥9.78 Million | CN¥1.35 Million | CN¥105.49 Million | ▲ +131.1% |
| 2003 | -0.30x | CN¥-30.94 Million | CN¥-41.13 Million | CN¥103.88 Million | ▼ -190.3% |
| 2002 | 0.33x | CN¥39.70 Million | CN¥21.80 Million | CN¥120.32 Million | ▲ +166.0% |
| 2001 | 0.12x | CN¥19.49 Million | CN¥10.52 Million | CN¥157.11 Million | ▲ +262.4% |
| 2000 | 0.03x | CN¥5.29 Million | CN¥-9.67 Million | CN¥154.60 Million | ▼ -95.1% |
| 1999 | 0.70x | CN¥66.62 Million | CN¥49.09 Million | CN¥95.68 Million | ▲ +183.3% |
| 1998 | 0.25x | CN¥21.46 Million | CN¥2.36 Million | CN¥87.30 Million | — |